GBP1 and glioma: The results from Kaplan-Meier analysis indicated that GBP1 could act as a risk factor for ovarian cancer and skin cutaneous melanoma, while it may serve as a protective factor for lower grade glioma, kidney renal papillary cell carcinoma, and uveal melanoma (Figure 8C, 8D).